HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E
Open Access
- 1 March 2018
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 92 (5) , e01749-17
Abstract
HIV-1-specific cytotoxic T cells (CTLs) play an important role in the control of HIV-1 subtype B or C infection. However, the role of CTLs in HIV-1 subtype A/E infection still remains unclear. Here we investigated the association of HLA class I alleles with clinical outcomes in treatment-naive Vietnamese infected with subtype A/E virus. We found that HLA-C*12:02 was significantly associated with lower plasma viral loads (pVL) and higher CD4 counts and that the HLA-A*29:01-B*07:05-C*15:05 haplotype was significantly associated with higher pVL and lower CD4 counts than those for individuals without these respective genotypes. Nine Pol and three Nef mutations were associated with at least one HLA allele in the HLA-A*29:01-B*07:05-C*15:05 haplotype, with a strong negative correlation between the number of HLA-associated Pol mutations and CD4 count as well as a positive correlation with pVL for individuals with these HLA alleles. The results suggest that the accumulation of mutations selected by CTLs restricted by these HLA alleles affects HIV control. IMPORTANCE Most previous studies on HLA association with disease progression after HIV-1 infection have been performed on cohorts infected with HIV-1 subtypes B and C, whereas few such population-based studies have been reported for cohorts infected with the Asian subtype A/E virus. In this study, we analyzed the association of HLA class I alleles with clinical outcomes for 536 HIV-1 subtype A/E-infected Vietnamese individuals. We found that HLA-C*12:02 is protective, while the HLA haplotype HLA-A*29:01-B*07:05-C*15:05 is deleterious. The individuals with HIV-1 mutations associated with at least one of the HLA alleles in the deleterious HLA haplotype had higher plasma viral loads and lower CD4 counts than those of individuals without the mutations, suggesting that viral adaptation and escape from HLA-mediated immune control occurred. The present study identifies a protective allele and a deleterious haplotype for HIV-1 subtype A/E infection which are different from those identified for cohorts infected with HIV-1 subtypes B and C.Keywords
Funding Information
- Joint Usage/Research Center on Tropical Diseases, Institute of Tropical Medicine, Nagasaki University
- Intramural Research Program of the NIH, Frederick National Lab, Center for Cancer Research
- HHS | NIH | National Cancer Institute (HHSN261200800001E)
- MEXT | Japan Society for the Promotion of Science (15H02658)
This publication has 27 references indexed in Scilit:
- Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective HaplotypeThe Journal of Infectious Diseases, 2017
- HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE InfectionAIDS Research and Human Retroviruses, 2016
- Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved EpitopesJournal of Virology, 2015
- Differential Clade-Specific HLA-B*3501 Association with HIV-1 Disease Outcome Is Linked to Immunogenicity of a Single Gag EpitopeJournal of Virology, 2012
- HLA Class I-Mediated Control of HIV-1 in the Japanese Population, in Which the Protective HLA-B*57 and HLA-B*27 Alleles Are AbsentJournal of Virology, 2012
- Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 InfectionJournal of Virology, 2010
- Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic ImplicationsJournal of Virology, 2007
- The Influence ofHLAGenotype on AIDSAnnual Review of Medicine, 2003
- HLA and AIDS: a cautionary taleTrends in Molecular Medicine, 2001
- HLAand HIV-1: Heterozygote Advantage andB*35-Cw*04DisadvantageScience, 1999